Budapest, Hungary

Ágnes Papp Née Behr

This inventor holds 1 USPTO granted patent. Top assignee: Gyogyszerkutato Intezet Kft.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ágnes Papp Née Behr. Retrieved from https://idiyas.com/inventor/andaacutegnes-papp-nandeacutee-behr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 23.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ágnes Papp Née Behr: Innovator in Pharmaceutical Chemistry

Introduction

Ágnes Papp Née Behr is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.

Latest Patents

He holds a patent for N-([1,4]benzodioxan-2-ylmethyl)-N-(3-chloro-1-propyl)-amine. This invention relates to R-2-[3-([1,4]benzodioxan-2-ylmethylamino)-1-propyl]-3(2H)-pyridazinone and S-2-[3-([1,4]benzodioxan-2-ylmethylamino)-1-propyl]-3(2H)-pyridazinone, along with their acid-addition salts and pharmaceutical compositions. The compounds exhibit α- and α-adrenoceptor antagonistic effects and urogenital selectivity, making them useful for treating benign prostate hyperplasia.

Career Highlights

Ágnes Papp Née Behr is associated with Gyogyszerkutato Intezet Kft., where he continues to advance his research and development efforts in pharmaceuticals. His work has been instrumental in creating innovative solutions for medical challenges.

Collaborations

He has collaborated with notable coworkers such as Éva Tomori Née Joszt and Alice Druga, contributing to the advancement of pharmaceutical research.

Conclusion

Ágnes Papp Née Behr is a distinguished inventor whose work in pharmaceutical chemistry has the potential to improve treatment options for patients. His innovative contributions continue to shape the field and enhance therapeutic practices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…